Back

BRIDGE: a barrier‑informed Bayesian risk prediction model for risk identification, trajectory grouping, and profiling of non‑adherence to cardioprotective medicines in primary care

30 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Updates on single and combined antithrombotic therapy Lipid-Lowering Agents ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speakers

Photo
Doctor Harvey Jia Wei Koh

Monash University, Melbourne (Australia)

Photo
Assistant Professor Stella Talic

Monash University, Melbourne (Australia)

5 More presentations in this session

Presentation thumbnail
Effect of combined antiplatelet and anticoagulant therapy in comparison to anticoagulants in monotherapy on CABG outcomes in patients requiring anticoagulants. Analysis of real-world data.
Doctor A. Segiet-Swiecicka (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Bleeding and mortality risks after intravenous alteplase in stroke patients with prior dual antiplatelet therapy: a nationwide cohort study
Doctor H. Huang (Hualien, TW)
Abstract Slides
Presentation thumbnail
Single vs. dual antithrombotic therapy in patients with stabilized coronary artery disease requiring long-term oral anticoagulation: A Bayesian meta-analysis
Doctor P. Sabouret (Paris, FR)
Abstract Slides
Presentation thumbnail
Antithrombotic therapy in patients with atrial fibrillation after percutaneous coronary intervention: a systematic review and individual patient data network meta-analysis.
Doctor C. Gibson (Boston, US) Assistant Professor M. Chiarito (Rozzano, IT)
Abstract Slides
Presentation thumbnail
Genotype-guided antiplatelet therapy after percutaneous coronary intervention: a systematic review and meta-analysis of randomised controlled trials.
Doctor A. Buffon (Rome, IT)
Abstract Slides

Access the full session

Session thumbnail
Updates on single and combined antithrombotic therapy

The Event

Event poster

ESC Congress 2026

30 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Trajectories of adherence to secondary prevention pharmacotherapy after coronary angiography: a retrospective population-based study
1 September 2025
thumbnail
Congress Presentation
Using bayesian method and network meta-analysis to augment the trial interpretation of RAAS inhibitor effects in patients
21 May 2023
thumbnail
Congress Presentation
Impact of ABC pathway adherence in high-risk patients with atrial fibrillation: an analysis from the ESC-EHRA EORP-AF long-term general registry
27 August 2022
thumbnail
Congress Presentation
A national project to improve the quality of secondary prevention strategies: the results of the BRING-UP Prevention study
5 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources